GETNET AYELEDURESA HUSSEINHYDER NEGASH2025-04-042025-06https://rps.wku.edu.et/handle/123456789/45959Background: Tetanus is a bacterial disease caused by the bacterium Clostridium tetani which is a highly fatal, non-communicable, and toxin-mediated disease. The main strategy to prevent the disease is immunization with protective dose of tetanus toxoid vaccine. But globally, maternal and neonatal tetanus is a public health problem due to low maternal tetanus toxoid vaccination. Ethiopia has highest neonatal mortality and morbidity related to tetanus in the world due to low tetanus toxoid immunization coverage. Despite several studies were conducted in Ethiopia on tetanus toxoid vaccination coverage, there is no well-known study done in the study area. Objectives: The aim of this study was to assess tetanus toxoid vaccine utilization and associated factors among pregnant women attending Wolkite University Specialized Hospital Gurage Central Ethiopia 2024GC. Methods: An institutional-based cross-sectional study design was conducted among 240 pregnant women visiting for antenatal care at Wolkite University Specialized Teaching Hospital. Study participant was selected using Systematic random sampling technique and the data was collected through an Interviewer-administered questionnaire. The collected data was entered into SPSS version 27 and analyze using the SPSS, bi-variable and multivariable logistic regression was computed. The p-value P < 0.05 was used to declare the final statistical significance. Result; The total tetanus vaccine intake (TT+2) doses were 77.7%.Mothers whose age ≥ 30 [(AOR 4.24 95%CI (1.04 - 17.25) ], Mothers who attended primary school [(AOR 4.55 ,95%CI (1.040- 19.89)], mothers whose husbands had diploma and above education [(AOR :6.63: 95% CI (1.02 - 43.35)], Advice on TT vaccine [AOR= 4 :95% CI:(1.22 -13.003],appropriate behavior of health workers [AOR= 7.6: 95% CI; (1.22 - 47.36)], good quality service [AOR: 4.62 95% CI (1.13 - 18.90)] and mother who have Good knowledge about TT vaccine and utilization [(AOR: 3.76, 95% CI: (1.276 - 11.06)] were significantly associated with TT vaccine utilization. Conclusion: In general, the utilization of protective doses of TT vaccination among participants in the area was low as compared to the WHO‘s recommendation for pregnant mothers 100% and the national figure. The most influencing factors in TT vaccine utilization were mother age, the mother and her husband‘s low educational level, advice about TT at ANC, the quality of service, IX the healthcare provider‘s behavior, and the mother‘s knowledge about TT vaccine and utilization.enTetanus toxoidImmunizationpregnant mothersutilizationThesis